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Abstract
Mammary sarcomas are very uncommon and make up less than 1% of all primary breast
malignancies.
Primary osteosarcoma of the breast is extremely rare and represents 12.5% of mammary sarcomas.
A secondary lesion from a primary osteosarcoma of the bone should be considered in the
differential diagnosis. In addition, the absence of a direct connection between the tumour and the
underlying skeleton is mandatory for the diagnosis.
We report a case of primary osteosarcoma of the breast occurring in young patient with fatal
evolution.
Introduction
Primary osteosarcoma of the breast is a very rare and
aggressive entity, which is histologically indistinguishable
from conventional osteosarcoma of the bone and other
extraskeletal [1].
In this report, we describe case with this uncommon
tumor.
Case report
An 38-year-old woman with a medical history of asthma
presented with a mass rising in the left breast without any
pain. Physical examination at admission revealed a
mobile mass in her right breast, estimated to be at least 8
cm. The mass was not attached to the sternum or the
underlying rib. No axillary lymphadenopathy was
detected on physical examination. The left breast was
unremarkable. On mammography, the mass was well
demarcated and partially calcified. An incisional biopsy
was performed, the histological exam showed abundant
cartilaginous proliferation varied from mature cartilage to
poorly differentiated areas. Immunohistochemical studie
was performed, immunoreactivity was detected for
vimentine but not for for AE1/AE3, CK7, CK20, estrogen
and progesterone receptors. There was also no overexpres-
sion of the HER-2/neu oncoprotein.
Liver echography, chest radiography and bone scan were
normal. The patient underwent simple mastectomy, just
after she presented dyspnea.
Chest radiography revealed a diffuse reticulonodular infil-
tration describing metastatic disease to the lung wich was
confirmed by CT-scann.
The patient was treated by association of doxorubicin 50
mg per square meter and cisplatinium 100 mg per square
meter every 21 day. The evaluation of the response basing
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on the CT scann showed a partial response after the third
cycle and progression of the disease after the sixth cycle.
The patient dead two months later.
Discussion
Mammary sarcomas are very uncommon and make up
less than 1% of all primary breast malignancies [1-3].
Primary osteosarcoma of the breast is extremely rare and
represents 12.5% of mammary sarcomas [1].
The histogenesis of primary osteosarcoma of the breast is
not clear, but an origin from totipotent mesenchymal cells
of the breast stroma or a transformation from a pre-exist-
ing fibroadenoma or phyllodes tumor has been suggested
[2-4]. Primary breast osteosarcomas are considered highly
aggressive tumors associated with early recurrence and a
propensity for haematogenous rather than lymphatic
spread, most commonly to the lungs [1,2].
Mammographically, these tumors often present as a well-
circumscribed dense lesion within the breast parenchyma
with focal or extensive coarse calcifications[1,5]. The
mammographic features may be deceptively benign [1].
Osteosarcoma of the breast, similar to other extraskeletal
osteosarcomas, may have a broad primary osteosarcomas
of the breast are fibroblastic, osteoblastic, osteoclastic
(giant cell-rich) and fibroblastic subtypes [4-6].
The diagnosis of metaplastic mammary carcinoma should
be excluded before primary breast osteosarcoma is diag-
nosed. The term sarcomatoid carcinoma has been adapted
to reflect the appearance of a mesenchymal neoplasm in
these epithelial malignancies. The term carcinosarcoma
has usually been used to describe biphasic tumors com-
posed of distinguishable malignant epithelial and sarco-
matoid components with heterologous elements [4,5].
A secondary lesion from a primary osteosarcoma of the
bone should be considered in the differential diagnosis.
In addition, the diagnosis of primary breast osteosarcoma
similar to that of other extraskeletal tumors requires the
absence of a direct connection between the tumor and the
underlying skeleton [7,8].
Treatment for the localized disease should include com-
plete surgical removal of the tumor with an adequate mar-
gin. Axillary lymph node dissection is not indicated
because axillary node involvement is exceptional.
Whereas, for the metastatic disease the chemotherapy bas-
ing on the classic drugs (doxorubicine, ifosfamide, cisplat-
inium, methotrexate) in the osteosarcoma is the main
treatment [8,9].
Although no standard of care for these lesions has been
made because the rarity of this entity [1,7,9].
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